Abstract:Misfolding and aggregation of amyloid peptides are the key pathological events in many neurodegenerative diseases. The development of effective inhibitors and drugs to prevent amyloid peptide aggregation is considered as an important therapeutic strategy for treating these diseases. We previously reported on tanshinones, ingredients from the Chinese herb Danshen (Salvia miltiorrhiza Bunge), as a potent inhibitor against amyloid-β1-42 (Aβ) aggregation and toxicity. Considering the common structural and aggregation features, and the correlation of type II diabetes (T2D) and Alzheimer's disease (AD), herein we examine the inhibition activity of two tanshinone I (TS1) and IIA (TS2) components on the aggregation and toxicity of hIAPP1-37 using combined experimental and computational approaches. Collective experimental data from ThT, CD, and AFM confirm that both tanshinones show comparable inhibition ability to reduce hIAPP aggregates by inhibiting the fibrillation process and changing the fibrillogenesis pathway, leading to the formation of some amorphous aggregates. More importantly, both tanshinones are capable of disassembling preformed hIAPP fibrils, but TS1 shows better potency in fibril dissembling than TS2. MTT and LDH assays also show that the tanshinones at very low concentrations of 5 μM can reduce the hIAPP-induced cell toxicity. Molecular dynamics (MD) simulations further reveal that both tanshinones preferentially bind to β-sheets to prevent lateral association of hIAPP aggregates and thus to inhibit fibril growth, explaining experimental observations. This work discovers that tanshinones act as common inhibitors to inhibit the aggregation of both hIAPP and Aβ, disaggregate preformed hIAPP and Aβ amyloid fibrils, and protect cells from hIAPP- and Aβ-induced toxicity, making them very promising agents against AD, T2D, and probably other amyloid-misfolding diseases.

Triterpenoids impede the fibrillation and cytotoxicity of human islet amyloid polypeptide

Exploration of Isoquinoline Alkaloids As Potential Inhibitors Against Human Islet Amyloid Polypeptide

Procyanidine Resists the Fibril Formation of Human Islet Amyloid Polypeptide.

A natural hyperbranched proteoglycan inhibits IAPP amyloid fibrillation and attenuates beta-cell apoptosis

-Carboline Alkaloids Resist the Aggregation and Cytotoxicity of Human Islet Amyloid Polypeptide

Inhibition of human islet amyloid polypeptide or amylin aggregation by two manganese-salen derivatives

Regulation Of Artemisinin And Its Derivatives On The Assembly Behavior And Cytotoxicity Of Amyloid Polypeptides Hiapp And A Beta

Mechanism Study on the Abnormal Accumulation and Deposition of Islet Amyloid Polypeptide by Cold-Spray Ionization Mass Spectrometry.

Conformation-Dependent Manipulation of Human Islet Amyloid Polypeptide Fibrillation by Shiitake-Derived Lentinan.

Melatonin Inhibits hIAPP Oligomerization by Preventing β-Sheet and Hydrogen Bond Formation of the Amyloidogenic Region Revealed by Replica-Exchange Molecular Dynamics Simulation

Tetracycline Derivatives Resist the Assembly Behavior of Human Islet Amyloid Polypeptide

Inhibition of Human Amylin Fibril Formation by Insulin-Mimetic Vanadium Complexes

Hydrophobic/Hydrophilic Ratio of Amphiphilic Helix Mimetics Determines the Effects on Islet Amyloid Polypeptide Aggregation

Tanshinones Inhibit Hiapp Aggregation, Disaggregate Preformed Hiapp Fibrils, and Protect Cultured Cells.

Stabilities and Structures of Islet Amyloid Polypeptide (IAPP22-28) Oligomers: from Dimer to 16-Mer.

Inhibitory Mechanism of Epigallocatechin Gallate on Fibrillation and Aggregation of Amidated Human Islet Amyloid Polypeptide.

Synthesis of Yakuchinone B-Inspired Inhibitors against Islet Amyloid Polypeptide Aggregation

Regulation of oxaliplatin and carboplatin on the assembly behavior and cytotoxicity of human islet amyloid polypeptide

Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation

Non-polyphenolic Natural Inhibitors of Amyloid Aggregation

Silibinin Inhibits the Toxic Aggregation of Human Islet Amyloid Polypeptide